Literature DB >> 8886825

The relationship between lipoprotein(a) and low density lipoprotein receptors during the treatment of hyperthyroidism.

H Hayashi1, N Mizushima, H Yoshinaga, H Kawamitsu, S Matsuda, M Tanoue, H Kurosawa, H Fujimoto, T Amakawa.   

Abstract

To determine whether the low density lipoprotein (LDL) receptor pathway is involved in the catabolism of plasma lipoprotein (a) [Lp(a)], serum lipids, Lp(a), and LDL receptor activity were measured in seven patients with hyperthyroidism before and after methimazole treatment given hyperthyroidism is associated with enhanced LDL receptor activity. LDL receptor activity in patients was estimated by the equation using the serum concentrations of apolipoprotein (apo) B and C-II. When euthyroidism was achieved after treatment, not only did serum total cholesterol, high density lipoprotein-cholesterol, apo B, and LDL-cholesterol (LDL-Ch) levels rise, but Lp(a) significantly increased and calculated LDL receptor activity significantly decreased. The changes in LDL receptor activity were significantly correlated with the changes in LDL-Ch as expected, but not with changes in Lp(a). These results suggest that the serum concentration of Lp(a) is lowered in hyperthyroidism, probably by a mechanism other than the enhanced activity of the LDL receptor, and that the LDL receptor pathway is involved in the catabolism of Lp(a) to a limited extent.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8886825     DOI: 10.1055/s-2007-979821

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  2 in total

1.  Lipid abnormalities and cardiometabolic risk in patients with overt and subclinical thyroid disease.

Authors:  Melpomeni Peppa; Grigoria Betsi; George Dimitriadis
Journal:  J Lipids       Date:  2011-07-18

2.  Relationship between high normal TSH levels and metabolic syndrome components in type 2 diabetic subjects with euthyroidism.

Authors:  Lilit Petrosyan
Journal:  J Clin Transl Endocrinol       Date:  2015-02-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.